Mapping the Binding Site for Matrix Metalloproteinase on the N-Terminal Domain of the Tissue Inhibitor of Metalloproteinases-2 by NMR Chemical Shift Perturbation
Citations Over TimeTop 13% of 1997 papers
Abstract
Changes in the NMR chemical shift of backbone amide nuclei (1H and 15N) have been used to map the matrix metalloproteinase (MMP) binding site on the N-terminal domain of the tissue inhibitor of metalloproteinase-2 (N-TIMP-2). Amide chemical shift changes were measured on formation of a stable complex with the catalytic domain of stromelysin-1 (N-MMP-3). Residues with significantly shifted amide signals mapped specifically to a broad site covering one face of the molecule. This site (the MMP binding site) consists primarily of residues 1-11, 27-41, 68-73, 87-90, and 97-104. The site overlaps with the OB-fold binding site seen in other proteins that share the same five-stranded beta-barrel topology. Sequence conservation data and recent site-directed mutagenesis studies are discussed in relation to the MMP binding site identified in this work.
Related Papers
- → Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer Effects(2015)15 cited
- → Production of tissue inhibitor of metalloproteinase-1 and -2 by cultured keratinocytes(2000)7 cited
- ヒト糸球体疾患の糸球体におけるmatrix metalloproteinase(MMP)-2、MMP-9、tissue inhibitor of metalloproteinase(TIMP)-1、TIMP-2の発現(2005)
- Recent Developments of Study about The Relationship of Matrix Metalloproteinase,Tissue Inhibitor of Metalloproteinase with Invasion of Meningiomas(2007)